Key facts
- It has raised $100K; the latest was Early Stage VC ($100K) in Feb 2026.
- Notable investors include Illinois Ventures, Heinz Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Auvi Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Auvi Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Auvi Labs
Developer of a remote monitoring device designed to detect fistula failure in dialysis patients. The company's device uses various sensors and a proprietary algorithm to detect fistula failure before it happens, enabling medical professionals to improve patient care by making their treatment less painful and cost-effective.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2024
- Employees
- 5
- Website
- auvilabs.com/
- Ownership
- Privately Held (backing)
Auvi Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Auvi Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Auvi Labs in its N-PORT filings yet. We sweep new filings monthly.